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Effects of glucosamine on the catabolism of aggrecan in articular
cartilage
M. Z. Ilic, B. Martinac and C. J. Handley
School of Human Biosciences, LaTrobe University, Melbourne, Australia
Aim: Aim of study was to establish the outcome of the long-term exposure of explant cultures of articular cartilage to GlcN on the stimulated
aggrecan loss from the tissue.
Methods: The loss of 35S-labelled and chemical levels of aggrecan, from the matrix of retinoic acid stimulated articular cartilage explants
maintained in the presence of GlcN at concentrations of up to 10 mM for period of 9 days, was determined. The prophylactic effect of
glucosamine (GlcN) on aggrecan degradation was investigated by treating the articular cartilage cultures with 5 mM GlcN for 5 days and then
continuing the culture for further 10 days. The direct effect of GlcN on aggrecanase acitvity was investigated using soluble aggrecanase
activity derived from cultures of synovial capsule to digest aggrecan monomer in the presence of GlcN. The effect of GlcN on the metabolic
activity of chondrocytes was assessed by lactate production and protein synthesis.
Results: GlcN inhibited aggrecan degradation in explant cultures of articular cartilage stimulated with retinoic acid in a dose dependant
manner. The withdrawal of GlcN from the cultures resulted in an enhanced loss of aggrecan from the matrix similar to control cultures. GlcN
did not inhibit soluble aggrecanase activity. GlcN did not have an adverse effect on the chondrocyte metabolism.
Conclusions: GlcN inhibited stimulated loss of aggrecan from explant cultures of articular cartilage but this effect did not persist when it was
removed from the culture medium. The effect of GlcN on the degradation on aggrecan is likely to be through the regulation of aggrecanase
activity and not through the direct inhibition of aggrecanase activity.
T cell–chondrocyte interaction in osteoarthritis
M. Tanaka1, H. Nakamura1, A. Shibakawa2, K. Masuko-Hongo1, T. Kato1, K. Nishioka1
1Institute of Medical Science, St. Marianna University, Kawasaki, Japan
2Department of Orthopedic Surgery, St. Marianna University, Kawasaki, Japan
Aim of study: To clarify the effect of direct contact between chondrocytes and autologous T cells in osteoarthritis (OA), in terms of RANTES
and MMPs production.
Methods: Cartilage samples were obtained from patients with OA and femoral neck fracture. Chondrocytes from the latter patients were
served as a normal control. Chondrocytes were co-cultured with autologous T cells for 3 days or cultured individually. The supernatant (sup.)
was collected to measure RANTES, MMP-1, -3, and -13 levels and the production ratio (PR) was calculated as follows; PR=[sup. of
co-culture]/([sup. of chondrocyte culture]+[sup. of T cell culture]). Additionally, to elucidate whether the T cell–chondrocyte interaction was
mediated by humoral factor or not, OA chondrocytes and autologous T cells were cultured in the same well using Transwell® system for
3 days.
Results: PR of RANTES was enhanced only in OA (PR1.7980.401, p<0.05), but not in normal (PR0.9510.072) by co-culture of
chondrocytes with autologous T cells. PRs of MMP-1, -3, and -13 were significantly up-regulated in direct co-culture, while these increases
were cancelled in indirect co-culture by Transwell.
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The effect of pralnacasan, an inhibitor of interleukin-1-converting
enzyme (caspase-1) on histopathologic damage and urinary collagen
crosslinks in male str/1n mice with spontaneous osteoarthritis of the
knee joint
Karl A. Rudolphi*, Nicole Gerwin*, Nicole Verzijl**
*Aventis Pharma Deutschland GmbH, Frankfurt/Main, Germany
**TNO Prevention and Health, Glaubius Laboratory, Leiden, The Netherlands
Aim: The pro-inflammatory cytokine interleukin-1β (IL-1β) is known to be a key mediator of joint pathology in osteoarthritis. IL-1β is produced
by interleukin-1β converting enzyme (ICE, a.k.a. Caspase-1). We studied the effect of pralnacasan an orally bioavailable pro-drug of a
potent, selective ICE-inhibitor, RU36384 (Ki 1.3 nM) on the histological degree of joint damage and the urinary excretion of collagen
degradation products in STR/1N mice, a mouse strain suffering from spontaneous osteoarthritis (OA) of the knee joints.
Methods: Three groups of 6-week-old male STR/1N mice (n25/group; BW: 25–27 g) were either fed standard food or a food-mixture
containing pralnacasan at concentrations of 700 and 4200 ppm (mg/kg) for 6 weeks. Urine samples were then collected to determine by
HPLC the concentration of Hydroxylysyl–Pyridinoline collagen crosslinks (HP, reflecting bone and cartilage degradation) and Lysyl–
Pyridinoline crosslinks (LP, reflecting bone degradation). Coronal paraffin-sections (7 µm) of the knee joints, stained with hematoxylin–eosin
and safranin-O were evaluated ‘blind’ for histopathological joint alterations by using a modified semi-quantitative Mankin score.
Results: The STR/1N mice developed typical histopathological OA changes predominantly in the medial part of the knee joint.
Pralnacasan-treatment (at 4200 ppm) significantly reduced histopathological OA damage in the medial tibial plateau of the knee joint (−12%)
and in the total medial part of the knee joint (femur plus tibia, −17%, p<0.05, rank–sum test). The concentration of urinary HP crosslinks and
the HP/LP ratio (predominantly reflecting cartilage degradation) were also significantly reduced by 55 and 85% (p<0.01, ANOVA),
respectively.
Conclusion: The significant reduction of structural joint damage by histopathologic evaluation and the marked reduction of urinary collagen
fragmentation products (pyridinoline crosslinks) in the STR/1N mouse model of spontaneous OA demonstrate the disease-modifying
potential of the orally active ICE inhibitor, pralnacasan, in OA. These data support further investigations, including initiation of clinical studies
in OA.
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